Dowsett M - Search Results

1

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.

Tutt A, Tovey H, Cheang MCU, Kernaghan S, Kilburn L, Gazinska P, Owen J, Abraham J, Barrett S, Barrett-Lee P, Brown R, Chan S, Dowsett M, Flanagan JM, Fox L, Grigoriadis A, Gutin A, Harper-Wynne C, Hatton MQ, Hoadley KA, Parikh J, Parker P, Perou CM, Roylance R, Shah V, Shaw A, Smith IE, Timms KM, Wardley AM, Wilson G, Gillett C, Lanchbury JS, Ashworth A, Rahman N, Harries M, Ellis P, Pinder SE, Bliss JM. Tutt A, et al. Among authors: dowsett m. Nat Med. 2018 May;24(5):628-637. doi: 10.1038/s41591-018-0009-7. Epub 2018 Apr 30. Nat Med. 2018. PMID: 29713086 Free PMC article. Clinical Trial.

2

A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome.

Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BA, Stratton MR. Wooster R, et al. Among authors: dowsett m. Nat Genet. 1992 Oct;2(2):132-4. doi: 10.1038/ng1092-132. Nat Genet. 1992. PMID: 1303262

3

The effect of a low-fat diet on hormone levels in healthy pre- and postmenopausal women: relevance for breast cancer.

Crighton IL, Dowsett M, Hunter M, Shaw C, Smith IE. Crighton IL, et al. Among authors: dowsett m. Eur J Cancer. 1992;28A(12):2024-7. doi: 10.1016/0959-8049(92)90252-w. Eur J Cancer. 1992. PMID: 1419300

4

Towards a molecular basis for tamoxifen resistance in breast cancer.

Johnston SR, Dowsett M, Smith IE. Johnston SR, et al. Among authors: dowsett m. Ann Oncol. 1992 Jul;3(7):503-11. doi: 10.1093/oxfordjournals.annonc.a058251. Ann Oncol. 1992. PMID: 1498070 Free article. Review.

5

An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients.

Dowsett M, Mehta A, King N, Smith IE, Powles TJ, Stein RC, Coombes RC. Dowsett M, et al. Eur J Cancer. 1992;28(2-3):415-20. doi: 10.1016/s0959-8049(05)80065-6. Eur J Cancer. 1992. PMID: 1591054 Clinical Trial.

6

Clinical and endocrine effects of leuprorelin acetate in pre- and postmenopausal patients with advanced breast cancer.

Dowsett M, Jacobs S, Aherne J, Smith IE. Dowsett M, et al. Clin Ther. 1992;14 Suppl A:97-103. Clin Ther. 1992. PMID: 1606596 Clinical Trial.

7

4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis.

Coombes RC, Wilkinson JR, Bliss JM, Shah P, Easton DF, Dowsett M. Coombes RC, et al. Among authors: dowsett m. Br J Cancer. 1991 Aug;64(2):247-50. doi: 10.1038/bjc.1991.285. Br J Cancer. 1991. PMID: 1892751 Free PMC article.

8

A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.

Dowsett M, Mehta A, Mansi J, Smith IE. Dowsett M, et al. Br J Cancer. 1990 Nov;62(5):834-7. doi: 10.1038/bjc.1990.388. Br J Cancer. 1990. PMID: 2123115 Free PMC article. Clinical Trial.

9

Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects.

Crighton IL, Dowsett M, Lal A, Man A, Smith IE. Crighton IL, et al. Among authors: dowsett m. Br J Cancer. 1989 Oct;60(4):644-8. doi: 10.1038/bjc.1989.331. Br J Cancer. 1989. PMID: 2508735 Free PMC article.

10

Role of aminoglutethimide in male breast cancer.

Harris AL, Dowsett M, Stuart-Harris R, Smith IE. Harris AL, et al. Among authors: dowsett m. Br J Cancer. 1986 Oct;54(4):657-60. doi: 10.1038/bjc.1986.223. Br J Cancer. 1986. PMID: 3778807 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

738 results

Search Page